|

Non-vitamin K oral anticoagulant (NOAC) Clinical Trials

1 actively recruiting trial across 1 location

Also known as: Apixaban, Dabigatran, Edoxaban, Rivaroxaban

Pipeline

Phase 4: 1

Top Sponsors

  • Population Health Research Institute1

Indications

  • Heart Disease1
  • Atrial Fibrillation1
  • Stroke1

Los Angeles, California1 trial

Anticoagulation for Stroke Prevention In Patients With Recent Episodes of Atrial Fibrillation Occurring Transiently With Stress

Cedars-Sinai Medical Center

Phase 4

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.